Hammam Zmily is a Cardiology physician affiliated with Wayne State University. OpenAlex indexes 28 publications with 211 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1629 W Big Beaver Rd
Troy, MI 480843542
Telephone
248-480-0363Registry record last updated 18 Sept 2015.
Industry payments
17 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year20251 payment
- Novo Nordisk IncProgram year20252 payments
- ABBVIE INC.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
75.1%Beta blocker20.3%Metoprolol Succinate50%Carvedilol34%Metoprolol Tartrate17%Part D≥63 patientsStatin15.5%Atorvastatin Calcium86%Rosuvastatin Calcium14%Part D≥88 patients+ 13 more classes in this area
Blood & clotting
17.4%P2Y12 inhibitor9.6%Clopidogrel86%Brilinta14%Part D<11 patientsFactor Xa inhibitor7.8%Eliquis75%Xarelto25%Part D≥28 patientsMetabolism & gastrointestinal
7%SGLT2 inhibitor4.3%Farxiga51%Jardiance49%Part D≥11 patientsPotassium supplement1.6%Potassium Chloride100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- SEVERE ACUTE AORTIC INSUFFICIENCY DUE TO INFECTIVE ENDOCARDITIS IN A CANCER PATIENT: A MULTIDISCIPLINARY TEAM MANAGEMENT
Journal of the American College of Cardiology
2023 - Usefulness of the Mitral Regurgitation Severity Index to Assess the Severity of Chronic Mitral Regurgitation
The American Journal of Cardiology
2017 - Actinomycotic Endocarditis of the Eustachian Valve: A Rare Case and a Review of the Literature
Texas Heart Institute Journal
2015 - Actinomycotic Endocarditis of the Eustachian Valve2015
- <b>Evaluation of</b><b>lixivaptan</b><b>in euvolemic and hypervolemic hyponatremia and heart failure treatment</b>
Expert Opinion on Drug Metabolism & Toxicology
2013
Similar KOLs
Other experts from the same institution or the same specialty.
Sonia Hassan, MD
Wayne State University
Tinnakorn Chaiworapongsa, MD
Wayne State University
Robert Sokol, MD
Wayne State University
Robert Lisak, MD
Wayne State University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”